This chapter explores the rise and fall of 23andMe, a DNA testing company. It delves into the success of their ancestry testing model, but also uncovers the flaws in their testing accuracy and the challenges they faced in generating recurring revenue and predicting health problems.
In today’s episode for 6th February 2024, we explore how a once high-flying health tech company is on the verge of getting chucked out of the NASDAQ index.
If you're a person who is great at communicating and are enthusiastic to join our team, Ditto is looking to recruit new Insurance advisors. You don't even have to know about Insurance, we'll train you from scratch and you can enjoy working remotely with a great team. If you're interested in this or know someone who is please click this link. https://bit.ly/48WX5za